{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:53:26Z","timestamp":1777960406457,"version":"3.51.4"},"reference-count":153,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Schistosomiasis is a neglected tropical disease. It is related to long-lasting granulomatous fibrosis\nand inflammation of target organs, and current sub-optimal pharmacological treatment creates\nglobal public health concerns. Intravascular worms and eggs release antigens and extracellular vesicles\nthat target host endothelial cells, modulate the immune system, and stimulate the release of damageassociated\nmolecular patterns (DAMPs). ATP, one of the most studied DAMPs, triggers a cascade of\nautocrine and paracrine actions through purinergic P2X and P2Y receptors, which are shaped by ectonucleotidases\n(CD39). Both P2 receptor families, and in particular P2Y&lt;sub&gt;1&lt;\/sub&gt;, P2Y&lt;sub&gt;2&lt;\/sub&gt;, P2Y&lt;sub&gt;12&lt;\/sub&gt;, and P2X7 receptors,\nhave been attracting increasing interest in several inflammatory diseases and drug development.\nCurrent data obtained from the murine model unveiled a CD39-ADP-P2Y&lt;sub&gt;1&lt;\/sub&gt;\/P2Y&lt;sub&gt;12&lt;\/sub&gt; receptors signaling\npathway linked to the liver and mesenteric exacerbations of schistosomal inflammation. Therefore, we\nproposed that members of this purinergic signaling could be putative pharmacological targets to reduce\nschistosomal morbidity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026620666200924115113","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:59:29Z","timestamp":1601009969000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unveiling the Potential of Purinergic Signaling in Schistosomiasis Treatment"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-3921","authenticated-orcid":true,"given":"Nath\u00e1lia Ferreira","family":"Oliveira","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Biochemical Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-6036","authenticated-orcid":true,"given":"Claudia Lucia Martins","family":"Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Biochemical Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"McManus D.P.","year":"2018","unstructured":"McManus D.P.; Dunne D.W.; Sacko M.; Utzinger J.; Vennervald B.J.; Zhou X-N.; Schistosomiasis. Nat Rev Dis Primers 2018,4(1),13","journal-title":"Nat Rev Dis Primers"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21542\/gcsp.2019.5","volume":"2019","author":"Butrous G.","year":"2019","unstructured":"Butrous G.; Schistosome infection and its effect on pulmonary circulation. Glob Cardiol Sci Pract 2019,2019(1),5","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref=3","unstructured":"World Health Organization (WHO) http:\/\/www.who.int\/schistosomiasis\/en\/2020"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006144","volume":"12","author":"Osakunor D.N.M.","year":"2018","unstructured":"Osakunor D.N.M.; Woolhouse M.E.J.; Mutapi F.; Paediatric schistosomiasis: What we know and what we need to know. PLoS Negl Trop Dis 2018,12(2)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.actatropica.2013.12.001","volume":"141","author":"King C.H.","year":"2015","unstructured":"King C.H.;  Health metrics for helminth infections  Acta Trop 2015,141(Pt B),150-160","journal-title":"Health metrics for helminth infections  Acta Trop"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1473-3099(16)30475-3","volume":"17","author":"Mutapi F.","year":"2017","unstructured":"Mutapi F.; Maizels R.; Fenwick A.; Woolhouse M.; Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017,17(2),e42-e48","journal-title":"Lancet Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1473-3099(15)00084-5","volume":"15","author":"Boissier J.","year":"2015","unstructured":"Boissier J.; Mon\u00e9 H.; Mitta G.; Bargues M.D.; Molyneux D.; Mas-Coma S.; Schistosomiasis reaches Europe. Lancet Infect Dis 2015,15(7),757-758","journal-title":"Lancet Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"Gryseels B.","year":"2006","unstructured":"Gryseels B.; Polman K.; Clerinx J.; Kestens L.; Human schistosomiasis. Lancet 2006,368(9541),1106-1118","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","volume":"36","author":"Colley D.G.","year":"2014","unstructured":"Colley D.G.; Secor W.E.; Immunology of human schistosomiasis. Parasite Immunol 2014,36(8),347-357","journal-title":"Parasite Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","volume":"2","author":"Pearce E.J.","year":"2002","unstructured":"Pearce E.J.; MacDonald A.S.; The immunobiology of schistosomiasis. Nat Rev Immunol 2002,2(7),499-511","journal-title":"Nat Rev Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jare.2013.01.005","volume":"4","author":"Barsoum R.S.","year":"2013","unstructured":"Barsoum R.S.; Esmat G.; El-Baz T.; Human schistosomiasis: clinical perspective: review J Adv Res 2013,4(5),433-444","journal-title":"J Adv Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hec.3833","volume":"28","author":"Barrenho E.","year":"2019","unstructured":"Barrenho E.; Miraldo M.; Smith P.C.; Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries. Health Econ 2019,28(1),123-143","journal-title":"Health Econ"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000504","volume":"3","author":"Melman S.D.","year":"2009","unstructured":"Melman S.D.; Steinauer M.L.; Cunningham C.; Kubatko L.S.; Mwangi I.N.; Wynn N.B.; Mutuku M.W.; Karanja D.M.S.; Colley D.G.; Black C.L.B.; Secor W.E.; Mkoji G.M.; Loker E.S.; Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 2009,3(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2174\/1568026618666181029143214","volume":"18","author":"Thomas C.M.","year":"2018","unstructured":"Thomas C.M.; Timson D.J.;  The mechanism of action of praziquantel: six hypotheses Curr Top Med Chem 2018,18(18),1575-1584","journal-title":"The mechanism of action of praziquantel: six hypotheses Curr Top Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/0006-2952(94)90464-2","volume":"48","author":"Masimirembwa C.M.","year":"1994","unstructured":"Masimirembwa C.M.; Hasler J.A.; Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochem Pharmacol 1994,48(9),1779-1783","journal-title":"Biochem Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ebiom.2017.02.017","volume":"17","author":"Rajman I.","year":"2017","unstructured":"Rajman I.; Knapp L.; Morgan T.; Masimirembwa C.; African genetic diversity: implications for cytochrome P450-mediated drug metabolism and drug development. EBioMedicine 2017,17,67-74","journal-title":"EBioMedicine"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcp.2017.07.016","volume":"151","author":"Burnstock G.","year":"2018","unstructured":"Burnstock G.; The therapeutic potential of purinergic signalling. Biochem Pharmacol 2018,151,157-165","journal-title":"Biochem Pharmacol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.drudis.2010.05.011","volume":"15","author":"Jacobson K.A.","year":"2010","unstructured":"Jacobson K.A.; Boeynaems J.M.; P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 2010,15(13-14),570-578","journal-title":"Drug Discov Today"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1748-1716.2009.01957.x","volume":"195","author":"Burnstock G.","year":"2009","unstructured":"Burnstock G.; Verkhratsky A.;  Evolutionary origins of the purinergic signalling system Acta Physiol, (Oxf) 2009,195,415-447","journal-title":"Evolutionary origins of the purinergic signalling system Acta Physiol, (Oxf)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/bies.201400024","volume":"36","author":"Verkhratsky A.","year":"2014","unstructured":"Verkhratsky A.; Burnstock G.; Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance. BioEssays 2014,36(7),697-705","journal-title":"BioEssays"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","volume":"99","author":"Burnstock G.","year":"2014","unstructured":"Burnstock G.; Purinergic signalling: from discovery to current developments. Exp Physiol 2014,99(1),16-34","journal-title":"Exp Physiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/(SICI)1098-2299(199611\/12)39:3\/4<204::AID-DDR2>3.0.CO;2-V","volume":"39","author":"Burnstock G.","year":"1996","unstructured":"Burnstock G.;  Purinoceptors: ontogeny and phylogeny Drug Dev Res 1996,39,204-242","journal-title":"Purinoceptors: ontogeny and phylogeny Drug Dev Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature08160","volume":"460","author":"Berriman M.","year":"2009","unstructured":"Berriman M.; Haas B.J.; LoVerde P.T.; Wilson R.A.; Dillon G.P.; Cerqueira G.C.; Mashiyama S.T.; Al-Lazikani B.; Andrade L.F.; Ashton P.D.; Aslett M.A.; Bartholomeu D.C.; Blandin G.; Caffrey C.R.; Coghlan A.; Coulson R.; Day T.A.; Delcher A.; DeMarco R.; Djikeng A.; Eyre T.; Gamble J.A.; Ghedin E.; Gu Y.; Hertz-Fowler C.; Hirai H.; Hirai Y.; Houston R.; Ivens A.; Johnston D.A.; Lacerda D.; Macedo C.D.; McVeigh P.; Ning Z.; Oliveira G.; Overington J.P.; Parkhill J.; Pertea M.; Pierce R.J.; Protasio A.V.; Quail M.A.; Rajandream M.A.; Rogers J.; Sajid M.; Salzberg S.L.; Stanke M.; Tivey A.R.; White O.; Williams D.L.; Wortman J.; Wu W.; Zamanian M.; Zerlotini A.; Fraser-Liggett C.M.; Barrell B.G.; El-Sayed N.M.; The genome of the blood fluke Schistosoma mansoni. Nature 2009,460(7253),352-358","journal-title":"Nature"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature08140","volume":"460","author":"Zhou Y.","year":"2009","unstructured":"Zhou Y.; Zheng H.; Chen Y.; Zhang L.; Wang K.; Guo J.; Huang Z.;  The schistosoma japonicum genome sequencing and functional analysis consortium  The Schistosoma japonicum genome reveals features of host-parasite interplay Nature 2009,460,345-351","journal-title":"The schistosoma japonicum genome sequencing and functional analysis consortium  The Schistosoma japonicum genome reveals features of host-parasite interplay Nature"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng.1065","volume":"44","author":"Young N.D.","year":"2012","unstructured":"Young N.D.; Jex A.R.; Li B.; Liu S.; Yang L.; Xiong Z.; Li Y.; Cantacessi C.; Hall R.S.; Xu X.; Chen F.; Wu X.; Zerlotini A.; Oliveira G.; Hofmann A.; Zhang G.; Fang X.; Kang Y.; Campbell B.E.; Loukas A.; Ranganathan S.; Rollinson D.; Rinaldi G.; Brindley P.J.; Yang H.; Wang J.; Wang J.; Gasser R.B.; Whole-genome sequence of Schistosoma haematobium. Nat Genet 2012,44(2),221-225","journal-title":"Nat Genet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/1471-2164-13-617","volume":"13","author":"Silva L.L.","year":"2012","unstructured":"Silva L.L.; Marcet-Houben M.; Nahum L.A.; Zerlotini A.; Gabald\u00f3n T.; Oliveira G.; The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite\u2019s biology. BMC Genomics 2012,13,617","journal-title":"BMC Genomics"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"D728","DOI":"10.1093\/nar\/gks1087","volume":"41","author":"Zerlotini A.","year":"2013","unstructured":"Zerlotini A.; Aguiar E.R.; Yu F.; Xu H.; Li Y.; Young N.D.; Gasser R.B.; Protasio A.V.; Berriman M.; Roos D.S.; Kissinger J.C.; Oliveira G.; SchistoDB: an updated genome resource for the three key schistosomes of humans. Nucleic Acids Res 2013,41(Database issue),D728-D731","journal-title":"Nucleic Acids Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4155\/fmc.15.21","volume":"7","author":"Ferreira L.G.","year":"2015","unstructured":"Ferreira L.G.; Oliva G.; Andricopulo A.D.; Target-based molecular modeling strategies for schistosomiasis drug discovery. Future Med Chem 2015,7(6),753-764","journal-title":"Future Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666171011100532","volume":"23","author":"Serr\u00e3o V.H.B.","year":"2017","unstructured":"Serr\u00e3o V.H.B.; Pereira H.D.; de Souza J.R.T.; Romanello L.;  Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target Curr Pharm Des 2017,23(45)","journal-title":"Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target Curr Pharm Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0163-7258(83)90031-1","volume":"20","author":"Senft A.W.","year":"1983","unstructured":"Senft A.W.; Crabtree G.W.; Purine metabolism in the schistosomes: potential targets for chemotherapy. Pharmacol Ther 1983,20(3),341-356","journal-title":"Pharmacol Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2307\/3279457","volume":"61","author":"Levy M.G.","year":"1975","unstructured":"Levy M.G.; Read C.P.; Relation of tegumentary phosphohydrolase to purine and pyrimidine transport in Schistosoma mansoni. J Parasitol 1975,61(4),648-656","journal-title":"J Parasitol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2307\/3279455","volume":"61","author":"Levy M.G.","year":"1975","unstructured":"Levy M.G.; Read C.P.; Purine and pyrimidine transport in Schistosoma mansoni. J Parasitol 1975,61(4),627-632","journal-title":"J Parasitol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0166-6851(85)90086-6","volume":"16","author":"Dovey H.F.","year":"1985","unstructured":"Dovey H.F.; McKerrow J.H.; Wang C.C.; Action of tubercidin and other adenosine analogs on Schistosoma mansoni schistosomules. Mol Biochem Parasitol 1985,16(2),185-198","journal-title":"Mol Biochem Parasitol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.pt.2009.03.004","volume":"25","author":"Bhardwaj R.","year":"2009","unstructured":"Bhardwaj R.; Skelly P.J.;  Purinergic signaling and immune modulation at the schistosome surface? Trends Parasitol 2009,25(6),256-260","journal-title":"Purinergic signaling and immune modulation at the schistosome surface? Trends Parasitol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s11302-014-9416-5","volume":"10","author":"Da\u2019dara A.A.","year":"2014","unstructured":"Da\u2019dara A.A.; Bhardwaj R.; Skelly P.J.; Schistosome apyrase SmATPDase1, but not SmATPDase2, hydrolyses exogenous ATP and ADP. Purinergic Signal 2014,10(4),573-580","journal-title":"Purinergic Signal"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1055\/s-0038-1641715","volume":"118","author":"Elzoheiry M.","year":"2018","unstructured":"Elzoheiry M.; Da\u2019dara A.A.; deLaforcade A.M.; El-Beshbishi S.N.; Skelly P.J.; The essential ectoenzyme SmNPP5 from the human intravascular parasite schistosoma mansoni is an ADPase and a potent inhibitor of platelet aggregation. Thromb Haemost 2018,118(6),979-989","journal-title":"Thromb Haemost"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0166-6851(93)90042-V","volume":"58","author":"Vasconcelos E.G.","year":"1993","unstructured":"Vasconcelos E.G.; Nascimento P.S.; Meirelles M.N.; Verjovski-Almeida S.; Ferreira S.T.; Characterization and localization of an ATP-diphosphohydrolase on the external surface of the tegument of Schistosoma mansoni. Mol Biochem Parasitol 1993,58(2),205-214","journal-title":"Mol Biochem Parasitol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1590\/S0074-02762011000700005","volume":"106","author":"Mendes R.G.","year":"2011","unstructured":"Mendes R.G.; Gusm\u00e3o M.A.; Maia A.C.; Detoni, Mde.L.; Porcino, G.N.; Soares, T.V.; Juliano, M.A.; Juliano, L.; Coelho, P.M.Z.; Lenzi, H.L.; Faria-Pinto, P.; Vasconcelos, E.G. Immunostimulatory property of a synthetic peptide belonging to the soluble ATP diphosphohydrolase isoform (SmATPDase 2) and immunolocalisation of this protein in the Schistosoma mansoni egg. Mem Inst Oswaldo Cruz 2011,106(7),808-813","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.dci.2011.03.026","volume":"35","author":"Maia A.C.","year":"2011","unstructured":"Maia A.C.; Detoni M.L.; Porcino G.N.; Soares T.V.; do Nascimento Gusm\u00e3o M.A.; Fessel M.R.; Marques M.J.; Souza M.A.; Coelho P.M.Z.; Estanislau J.A.G.; da Costa Rocha M.O.; de Oliveira Santos M.; Faria-Pinto P.; Vasconcelos E.G.;  Occurrence of a conserved domain in ATP diphosphohydrolases from pathogenic organisms associated to antigenicity in human parasitic diseases Dev Comp Immunol 2011,35(10),1059-1067","journal-title":"Occurrence of a conserved domain in ATP diphosphohydrolases from pathogenic organisms associated to antigenicity in human parasitic diseases Dev Comp Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.vph.2016.02.005","volume":"82","author":"Oliveira S.D.","year":"2016","unstructured":"Oliveira S.D.; Oliveira N.F.; Meyer-Fernandes J.R.; Savio L.E.; Ornelas F.G.; Ferreira Z.S.; Coutinho-Silva R.; Silva C.L.M.; Increased expression of NTPDases 2 and 3 in mesenteric endothelial cells during schistosomiasis favors leukocyte adhesion through P2Y1 receptors. Vascul Pharmacol 2016,82,66-72","journal-title":"Vascul Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0006-2952(74)90630-3","volume":"23","author":"Crabtree G.W.","year":"1974","unstructured":"Crabtree G.W.; Senft A.W.; Pathways of nucleotide metabolism in schistosoma mansoni. V. Adenosine cleavage enzyme and effects of purine analogues on adenosine metabolism in vitro. Biochem Pharmacol 1974,23(3),649-660","journal-title":"Biochem Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0006-2952(73)90287-6","volume":"22","author":"Stegman R.J.","year":"1973","unstructured":"Stegman R.J.; Senft A.W.; Brown P.R.; Parks R.E.; Pathways of nucleotide metabolism in Schistosoma mansoni. IV. Incorporation of adenosine analogs in vitro. Biochem Pharmacol 1973,22(4),459-468","journal-title":"Biochem Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1107\/S0907444912044800","volume":"69","author":"Romanello L.","year":"2013","unstructured":"Romanello L.; Bachega J.F.; Cassago A.; Brand\u00e3o-Neto J.; DeMarco R.; Garratt R.C.; Pereira H.D.; Adenosine kinase from Schistosoma mansoni: structural basis for the differential incorporation of nucleoside analogues. Acta Crystallogr D Biol Crystallogr 2013,69(Pt 1),126-136","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0166-6851(84)90062-8","volume":"11","author":"Dovey H.F.","year":"1984","unstructured":"Dovey H.F.; McKerrow J.H.; Wang C.C.;  Purine salvage in Schistosoma mansoni schistosomules Mol Biochem Parasitol 1984,11,157-167","journal-title":"Purine salvage in Schistosoma mansoni schistosomules Mol Biochem Parasitol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0020-7519(72)90013-6","volume":"2","author":"Senft A.W.","year":"1972","unstructured":"Senft A.W.;  Miech;  R.P.;  Brown;  F.R.;  Senft;  D.G.;  Purine metabolism in Schistosoma mansoni Int J Parasitol 1972,2,249-260","journal-title":"Purine metabolism in Schistosoma mansoni Int J Parasitol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1017\/S0031182007002600","volume":"134","author":"Angelucci F.","year":"2007","unstructured":"Angelucci F.; Basso A.; Bellelli A.; Brunori M.; Pica Mattoccia L.; Valle C.; The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology 2007,134(Pt 9),1215-1221","journal-title":"Parasitology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF00932019","volume":"81","author":"da Silva S.P.","year":"1995","unstructured":"da Silva S.P.; No\u00ebl F.; Time course of the effect of praziquantel on Schistosoma mansoni attachment in vitro: comparison with its effects on worm length and motility. Parasitol Res 1995,81(7),543-548","journal-title":"Parasitol Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"36873","DOI":"10.1074\/jbc.C100273200","volume":"276","author":"Kohn A.B.","year":"2001","unstructured":"Kohn A.B.; Anderson P.A.; Roberts-Misterly J.M.; Greenberg R.M.; Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J Biol Chem 2001,276(40),36873-36876","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bmc.2010.01.022","volume":"18","author":"Castilho M.S.","year":"2010","unstructured":"Castilho M.S.; Postigo M.P.; Pereira H.M.; Oliva G.; Andricopulo A.D.; Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: kinetic and structural studies. Bioorg Med Chem 2010,18(4),1421-1427","journal-title":"Bioorg Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12443","volume":"273","author":"Muller W.A.","year":"2016","unstructured":"Muller W.A.; Transendothelial migration: unifying principles from the endothelial perspective. Immunol Rev 2016,273(1),61-75","journal-title":"Immunol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.micinf.2012.09.001","volume":"14","author":"Wilson R.A.","year":"2012","unstructured":"Wilson R.A.; Virulence factors of schistosomes. Microbes Infect 2012,14(15),1442-1450","journal-title":"Microbes Infect"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.micinf.2010.06.001","volume":"12","author":"Schramm G.","year":"2010","unstructured":"Schramm G.; Haas H.; Th2 immune response against Schistosoma mansoni infection. Microbes Infect 2010,12(12-13),881-888","journal-title":"Microbes Infect"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2009.05.011","volume":"25","author":"Wilson R.A.","year":"2009","unstructured":"Wilson R.A.; Coulson P.S.; Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite\u2019s armour. Trends Parasitol 2009,25(9),423-431","journal-title":"Trends Parasitol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s004360050499","volume":"85","author":"Jacobs W.","year":"1999","unstructured":"Jacobs W.; van Dam G.; Bogers J.; Deelder A.; Van Marck E.; Schistosomal granuloma modulation. I. Schistosoma mansoni worm antigens CAA and CCA prime egg-antigen-induced hepatic granuloma formation. Parasitol Res 1999,85(1),7-13","journal-title":"Parasitol Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S0031182096008438","volume":"114","author":"Cutts L.","year":"1997","unstructured":"Cutts L.; Wilson R.A.;  The protein antigens secreted in vivo by adult male Schistosoma mansoni Parasitology 1997,114(Pt 3),245-255","journal-title":"The protein antigens secreted in vivo by adult male Schistosoma mansoni Parasitology"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0020-7519(94)E0067-W","volume":"25","author":"Al-Sherbiny M.","year":"1995","unstructured":"Al-Sherbiny M.; el Ridi R.; Guirguis N.I.; Dean D.A.; Identification and characterization of Schistosoma mansoni antigens recognized by T and B lymphocytes of humans with early active intestinal and\/or urinary schistosomiasis. Int J Parasitol 1995,25(1),113-121","journal-title":"Int J Parasitol"},{"key":"ref=57","first-page":"195","author":"Silva C.L.M.","year":"2015","unstructured":"Silva C.L.M.;  Endothelial cells as targets of the intravascular parasitic disease schistosomiasisVascular responses to pathogens; Gavins, FNE 2015,195-208","journal-title":"Endothelial cells as targets of the intravascular parasitic disease schistosomiasisVascular responses to pathogens; Gavins, FNE"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","volume":"49","author":"Maizels R.M.","year":"2018","unstructured":"Maizels R.M.; Smits H.H.; McSorley H.J.; Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules. Immunity 2018,49(5),801-818","journal-title":"Immunity"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fimmu.2018.00664","volume":"9","author":"Motran C.C.","year":"2018","unstructured":"Motran C.C.; Silvane L.; Chiapello L.S.; Theumer M.G.; Ambrosio L.F.; Volpini X.; Celias D.P.; Cervi L.; Cervi1, L. Helminth infections: recognition and modulation of the immune response by innate immune cells. Front Immunol 2018,9,664","journal-title":"Front Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fimmu.2013.00089","volume":"4","author":"Hams E.","year":"2013","unstructured":"Hams E.; Aviello G.; Fallon P.G.; The schistosoma granuloma: friend or foe? Front Immunol 2013,4,89","journal-title":"Front Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nri1601","volume":"5","author":"Dunne D.W.","year":"2005","unstructured":"Dunne D.W.; Cooke A.; A worm\u2019s eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005,5(5),420-426","journal-title":"Nat Rev Immunol"},{"key":"ref=62","first-page":"2033","volume":"150","author":"Jacobs W.","year":"1997","unstructured":"Jacobs W.; Bogers J.; Deelder A.; W\u00e9ry M.; Van Marck E.; Adult Schistosoma mansoni worms positively modulate soluble egg antigen-induced inflammatory hepatic granuloma formation in vivo. Stereological analysis and immunophenotyping of extracellular matrix proteins, adhesion molecules, and chemokines. Am J Pathol 1997,150(6),2033-2045","journal-title":"Am J Pathol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"20459","DOI":"10.1073\/pnas.1010337107","volume":"107","author":"Ritter M.","year":"2010","unstructured":"Ritter M.; Gross O.; Kays S.; Ruland J.; Nimmerjahn F.; Saijo S.; Tschopp J.; Layland L.E.; Prazeres da Costa C.; Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proc Natl Acad Sci USA 2010,107(47),20459-20464","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.110.002139","volume":"123","author":"Zerr M.","year":"2011","unstructured":"Zerr M.; Hechler B.; Freund M.; Magnenat S.; Lanois I.; Cazenave J-P.; L\u00e9on C.; Gachet C.; Major contribution of the P2Yreceptor in purinergic regulation of TNF\u03b1-induced vascular inflammation. Circulation 2011,123(21),2404-2413","journal-title":"Circulation"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"24960","DOI":"10.1074\/jbc.M301439200","volume":"278","author":"Seye C.I.","year":"2003","unstructured":"Seye C.I.; Yu N.; Jain R.; Kong Q.; Minor T.; Newton J.; Erb L.; Gonz\u00e1lez F.A.; Weisman G.A.; The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 2003,278(27),24960-24965","journal-title":"J Biol Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s004360050395","volume":"84","author":"Jacobs W.","year":"1998","unstructured":"Jacobs W.; Bogers J.J.; Timmermans J.P.; Deelder A.M.; Van Marck E.A.; Adhesion molecules in intestinal Schistosoma mansoni infection. Parasitol Res 1998,84(4),276-280","journal-title":"Parasitol Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2018.11.011","volume":"206","author":"Figliuolo da Paz V.R.","year":"2019","unstructured":"Figliuolo da Paz V.R.; Figueiredo-Vanzan D.; Dos Santos Pyrrho A.; Interaction and involvement of cellular adhesion molecules in the pathogenesis of Schistosomiasis mansoni. Immunol Lett 2019,206,11-18","journal-title":"Immunol Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3389\/fimmu.2018.02492","volume":"9","author":"Schwartz C.","year":"2018","unstructured":"Schwartz C.; Fallon P.G.; Schistosoma \u201ceggs-iting\u201d the host: granuloma formation and egg excretion. Front Immunol 2018,9,2492","journal-title":"Front Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.icb.7100014","volume":"85","author":"Wilson M.S.","year":"2007","unstructured":"Wilson M.S.; Mentink-Kane M.M.; Pesce J.T.; Ramalingam T.R.; Thompson R.; Wynn T.A.; Immunopathology of schistosomiasis. Immunol Cell Biol 2007,85(2),148-154","journal-title":"Immunol Cell Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4049\/jimmunol.164.5.2585","volume":"164","author":"Fallon P.G.","year":"2000","unstructured":"Fallon P.G.; Richardson E.J.; McKenzie G.J.; McKenzie A.N.; Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000,164(5),2585-2591","journal-title":"J Immunol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1128\/IAI.72.6.3391-3397.2004","volume":"72","author":"de Jesus A.R.","year":"2004","unstructured":"de Jesus A.R.; Magalh\u00e3es A.; Miranda D.G.; Miranda R.G.; Ara\u00fajo M.I.; de Jesus A.A.; Silva A.; Santana L.B.; Pearce E.; Carvalho E.M.; Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 2004,72(6),3391-3397","journal-title":"Infect Immun"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.4049\/jimmunol.176.10.5839","volume":"176","author":"Taylor J.J.","year":"2006","unstructured":"Taylor J.J.; Mohrs M.; Pearce E.J.; Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006,176(10),5839-5847","journal-title":"J Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/eji.201344098","volume":"44","author":"Deaton A.M.","year":"2014","unstructured":"Deaton A.M.; Cook P.C.; De Sousa D.; Phythian-Adams A.T.; Bird A.; MacDonald A.S.; A unique DNA methylation signature defines a population of IFN-\u03b3\/IL-4 double-positive T cells during helminth infection. Eur J Immunol 2014,44(6),1835-1841","journal-title":"Eur J Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1189\/jlb.0802418","volume":"73","author":"la Sala A.","year":"2003","unstructured":"la Sala A.; Ferrari D.; Di Virgilio F.; Idzko M.; Norgauer J.; Girolomoni G.; Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 2003,73(3),339-343","journal-title":"J Leukoc Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.113.008029","volume":"66","author":"Burnstock G.","year":"2013","unstructured":"Burnstock G.; Ralevic V.; Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 2013,66(1),102-192","journal-title":"Pharmacol Rev"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/cvr\/cvs187","volume":"95","author":"Lohman A.W.","year":"2012","unstructured":"Lohman A.W.; Billaud M.; Isakson B.E.; Mechanisms of ATP release and signalling in the blood vessel wall. Cardiovasc Res 2012,95(3),269-280","journal-title":"Cardiovasc Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"Idzko M.","year":"2014","unstructured":"Idzko M.; Ferrari D.; Eltzschig H.K.; Nucleotide signalling during inflammation. Nature 2014,509(7500),310-317","journal-title":"Nature"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1124\/pr.110.003129","volume":"63","author":"Coddou C.","year":"2011","unstructured":"Coddou C.; Yan Z.; Obsil T.; Huidobro-Toro J.P.; Stojilkovic S.S.; Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 2011,63(3),641-683","journal-title":"Pharmacol Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1124\/mol.114.095711","volume":"88","author":"Jacobson K.A.","year":"2015","unstructured":"Jacobson K.A.; Paoletta S.; Katritch V.; Wu B.; Gao Z-G.; Zhao Q.; Stevens R.C.; Kiselev E.; Nucleotides acting at P2Y receptors: connecting structure and function. Mol Pharmacol 2015,88(2),220-230","journal-title":"Mol Pharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pharmthera.2018.04.002","volume":"190","author":"Rafehi M.","year":"2018","unstructured":"Rafehi M.; M\u00fcller C.E.; Tools and drugs for uracil nucleotideactivated P2Y receptors. Pharmacol Ther 2018,190,24-80","journal-title":"Pharmacol Ther"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/j.1476-5381.2009.00337.x","volume":"157","author":"Jankowski V.","year":"2009","unstructured":"Jankowski V.; van der Giet M.; Mischak H.; Morgan M.; Zidek W.; Jankowski J.; Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system. Br J Pharmacol 2009,157(7),1142-1153","journal-title":"Br J Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.bbagen.2011.09.010","volume":"1810","author":"Fraga H.","year":"2011","unstructured":"Fraga H.; Fontes R.;  Enzymatic synthesis of mono and dinucleoside polyphosphates Biochim Biophys Acta 2011,1810(12),1195-1204","journal-title":"Enzymatic synthesis of mono and dinucleoside polyphosphates Biochim Biophys Acta"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11302-012-9304-9","volume":"8","author":"Lazarowski E.R.","year":"2012","unstructured":"Lazarowski E.R.; Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 2012,8(3),359-373","journal-title":"Purinergic Signal"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1124\/mol.64.4.785","volume":"64","author":"Lazarowski E.R.","year":"2003","unstructured":"Lazarowski E.R.; Boucher R.C.; Harden T.K.; Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003,64(4),785-795","journal-title":"Mol Pharmacol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"Robson S.C.","year":"2006","unstructured":"Robson S.C.; S\u00e9vigny J.; Zimmermann H.; The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2006,2(2),409-430","journal-title":"Purinergic Signal"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","volume":"104","author":"Jacobson K.A.","year":"2016","unstructured":"Jacobson K.A.; M\u00fcller C.E.;  Medicinal chemistry of adenosine, P2Y and P2X receptors Neuropharmacology 2016,104,31-49","journal-title":"Medicinal chemistry of adenosine, P2Y and P2X receptors Neuropharmacology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuropharm.2015.10.030","volume":"104","author":"von K\u00fcgelgen I.","year":"2016","unstructured":"von K\u00fcgelgen I.; Hoffmann K.;  Pharmacology and structure of P2Y receptors Neuropharmacology 2016,104,50-61","journal-title":"Pharmacology and structure of P2Y receptors Neuropharmacology"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.05.002","volume":"75","author":"Fuentes E.","year":"2015","unstructured":"Fuentes E.; Palomo I.; Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules. Vascul Pharmacol 2015,75,1-6","journal-title":"Vascul Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bcp.2011.06.017","volume":"82","author":"Gao Z.G.","year":"2011","unstructured":"Gao Z.G.; Verzijl D.; Zweemer A.; Ye K.; G\u00f6bly\u00f6s A.; Ijzerman A.P.; Jacobson K.A.; Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers. Biochem Pharmacol 2011,82(6),658-668","journal-title":"Biochem Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1111\/bph.14337","volume":"175","author":"Vecchio E.A.","year":"2018","unstructured":"Vecchio E.A.; Baltos J-A.; Nguyen A.T.N.; Christopoulos A.; White P.J.; May L.T.; New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism. Br J Pharmacol 2018,175(21),4036-4046","journal-title":"Br J Pharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","volume":"26","author":"Ciruela F.","year":"2006","unstructured":"Ciruela F.; Casad\u00f3 V.; Rodrigues R.J.; Luj\u00e1n R.; Burgue\u00f1o J.; Canals M.; Borycz J.; Rebola N.; Goldberg S.R.; Mallol J.; Cort\u00e9s A.; Canela E.I.; L\u00f3pez-Gim\u00e9nez J.F.; Milligan G.; Lluis C.; Cunha R.A.; Ferr\u00e9 S.; Franco R.; Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 2006,26(7),2080-2087","journal-title":"J Neurosci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bcp.2015.11.013","volume":"99","author":"Baltos J-A.","year":"2016","unstructured":"Baltos J-A.; Gregory K.J.; White P.J.; Sexton P.M.; Christopoulos A.; May L.T.; Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery. Biochem Pharmacol 2016,99,101-112","journal-title":"Biochem Pharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/mol.116.103283","volume":"90","author":"Baltos J-A.","year":"2016","unstructured":"Baltos J-A.; Paoletta S.; Nguyen A.T.N.; Gregory K.J.; Tosh D.K.; Christopoulos A.; Jacobson K.A.; May L.T.;  Structure-activity analysis of biased agonism at the human adenosine A3 receptor Mol Pharmacol 2016,90(1),12-22","journal-title":"Structure-activity analysis of biased agonism at the human adenosine A3 receptor Mol Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"North R.A.","year":"2002","unstructured":"North R.A.; Molecular physiology of P2X receptors. Physiol Rev 2002,82(4),1013-1067","journal-title":"Physiol Rev"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1124\/mol.107.035980","volume":"72","author":"Guo C.","year":"2007","unstructured":"Guo C.; Masin M.; Qureshi O.S.; Murrell-Lagnado R.D.; Evidence for functional P2X4\/P2X7 heteromeric receptors. Mol Pharmacol 2007,72(6),1447-1456","journal-title":"Mol Pharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1469-7793.1999.0335m.x","volume":"519","author":"Virginio C.","year":"1999","unstructured":"Virginio C.; MacKenzie A.; North R.A.; Surprenant A.; Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 1999,519(Pt 2),335-346","journal-title":"J Physiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"E2156","DOI":"10.1073\/pnas.1610414114","volume":"114","author":"Pippel A.","year":"2017","unstructured":"Pippel A.; Stolz M.; Woltersdorf R.; Kless A.; Schmalzing G.; Markwardt F.; Localization of the gate and selectivity filter of the full-length P2X7 receptor. Proc Natl Acad Sci USA 2017,114(11),E2156-E2165","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"41650","DOI":"10.1074\/jbc.M408203200","volume":"279","author":"Agboh K.C.","year":"2004","unstructured":"Agboh K.C.; Webb T.E.; Evans R.J.; Ennion S.J.; Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 2004,279(40),41650-41657","journal-title":"J Biol Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbamem.2005.01.009","volume":"1669","author":"Raouf R.","year":"2005","unstructured":"Raouf R.; Blais D.; S\u00e9gu\u00e9la P.; High zinc sensitivity and pore formation in an invertebrate P2X receptor. Biochim Biophys Acta 2005,1669(2),135-141","journal-title":"Biochim Biophys Acta"},{"key":"ref=100","first-page":"4","volume":"2019","author":"Ijzerman A.P.","year":"2019","unstructured":"Ijzerman A.P.; Fredholm B.; Jacobson K.A.; Linden J.; M\u00fceller C.; Frenguelli B.; Adenosine receptors (version 2019.4) in the IUPHAR\/BPS Guide to Pharmacology Database. Structure-activity Relat. Aden. Recept (2019)2019,2019,4","journal-title":"Recept"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"Zimmermann H.","year":"2012","unstructured":"Zimmermann H.; Zebisch M.; Str\u00e4ter N.; Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 2012,8(3),437-502","journal-title":"Purinergic Signal"},{"key":"ref=102","first-page":"S21","volume":"176","author":"Alexander S.P.H.","year":"2019","unstructured":"Alexander S.P.H.; Christopoulos A.; Davenport A.P.; Kelly E.; Mathie A.; Peters J.A.; Veale E.L.; Armstrong J.F.; Faccenda E.; Harding S.D.; Pawson A.J.; Sharman J.L.; Southan C.; Davies J.A.; (2019) The Concise guide to pharmacology 2019\/20: G protein-coupled receptors. Br J Pharmacol CGTP Collaborators2019,176(S1),S21-S141","journal-title":"Br J Pharmacol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharmthera.2005.04.012","volume":"112","author":"Volont\u00e9 C.","year":"2006","unstructured":"Volont\u00e9 C.; Amadio S.; D\u2019Ambrosi N.; Colpi M.; Burnstock G.; P2 receptor web: complexity and fine-tuning. Pharmacol Ther 2006,112(1),264-280","journal-title":"Pharmacol Ther"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2018.12.009","volume":"141","author":"Zhou Z.","year":"2019","unstructured":"Zhou Z.; Matsumoto T.; Jankowski V.; Pernow J.; Mustafa S.J.; Duncker D.J.; Merkus D.; Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update. Pharmacol Res 2019,141,32-45","journal-title":"Pharmacol Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"Abbracchio M.P.","year":"2006","unstructured":"Abbracchio M.P.; Burnstock G.; Boeynaems J-M.; Barnard E.A.; Boyer J.L.; Kennedy C.; Knight G.E.; Fumagalli M.; Gachet C.; Jacobson K.A.; Weisman G.A.; International union of pharmacology lviii: update on the p2y g protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006,58(3),281-341","journal-title":"Pharmacol Rev"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1074\/jbc.M709266200","volume":"283","author":"Choi R.C.Y.","year":"2008","unstructured":"Choi R.C.Y.; Simon J.; Tsim K.W.K.; Barnard E.A.; Constitutive and agonist-induced dimerizations of the P2Y1 receptor: relationship to internalization and scaffolding. J Biol Chem 2008,283(16),11050-11063","journal-title":"J Biol Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fimmu.2019.00507","volume":"10","author":"Vuerich M.","year":"2019","unstructured":"Vuerich M.; Robson S.C.; Longhi M.S.;  Ectonucleotidases in intestinal and hepatic inflammation Front Immunol 2019,10,507","journal-title":"Ectonucleotidases in intestinal and hepatic inflammation Front Immunol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"Allard B.","year":"2017","unstructured":"Allard B.; Longhi M.S.; Robson S.C.; Stagg J.; The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev 2017,276(1),121-144","journal-title":"Immunol Rev"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1002\/eji.201141512","volume":"41","author":"Regateiro F.S.","year":"2011","unstructured":"Regateiro F.S.; Howie D.; Nolan K.F.; Agorogiannis E.I.; Greaves D.R.; Cobbold S.P.; Waldmann H.; Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-\u03b2. Eur J Immunol 2011,41(10),2955-2965","journal-title":"Eur J Immunol"},{"key":"ref=110","first-page":"139","volume":"60","author":"Aird W.C.","year":"2008","unstructured":"Aird W.C.; Endothelium in health and disease. Pharmacol Rep 2008,60(1),139-143","journal-title":"Pharmacol Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2172-5-5","volume":"5","author":"Rothermel A.L.","year":"2004","unstructured":"Rothermel A.L.; Wang Y.; Schechner J.; Mook-Kanamori B.; Aird W.C.; Pober J.S.; Tellides G.; Johnson D.R.; Endothelial cells present antigens in vivo. BMC Immunol 2004,5,5","journal-title":"BMC Immunol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"Pober J.S.","year":"2007","unstructured":"Pober J.S.; Sessa W.C.; Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007,7(10),803-815","journal-title":"Nat Rev Immunol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1189\/jlb.0904554","volume":"77","author":"Cook-Mills J.M.","year":"2005","unstructured":"Cook-Mills J.M.; Deem T.L.; Active participation of endothelial cells in inflammation. J Leukoc Biol 2005,77(4),487-495","journal-title":"J Leukoc Biol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","volume":"288","author":"Vila E.","year":"2005","unstructured":"Vila E.; Salaices M.; Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005,288(3),H1016-H1021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=115","first-page":"195","author":"Silva C.L.M.","year":"2015","unstructured":"Silva C.L.M.; Endothelial cells as targets of the intravascular parasitic disease schistosomiasis. Vascular Responses to Pathogens 2015,195-207","journal-title":"Vascular Responses to Pathogens"},{"key":"ref=116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023547","volume":"6","author":"Oliveira S.D.","year":"2011","unstructured":"Oliveira S.D.; Quintas L.E.; Amaral L.S.; No\u00ebl F.; Farsky S.H.; Silva C.L.; Increased endothelial cell-leukocyte interaction in murine schistosomiasis: possible priming of endothelial cells by the disease. PLoS One 2011,6(8)","journal-title":"PLoS One"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1095-6433(98)10041-7","volume":"120","author":"Silva C.L.","year":"1998","unstructured":"Silva C.L.; Morel N.; Lenzi H.L.; No\u00ebl F.; Increased reactivity to 5-hydroxytryptamine of portal veins from mice infected with Schistosoma mansoni. Comp Biochem Physiol A Mol Integr Physiol 1998,120(3),417-423","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11302-012-9332-5","volume":"9","author":"Oliveira S.D.","year":"2013","unstructured":"Oliveira S.D.; Coutinho-Silva R.; Silva C.L.; Endothelial P2X7 receptors\u2019 expression is reduced by schistosomiasis. Purinergic Signal 2013,9(1),81-89","journal-title":"Purinergic Signal"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1590\/S0074-02762011000400012","volume":"106","author":"Oliveira S.D.","year":"2011","unstructured":"Oliveira S.D.; Silva C.L.M.; Schistosomiasis differentially affects vasoconstrictor responses: up-regulation of 5-HT receptor-mediated aorta contraction. Mem Inst Oswaldo Cruz 2011,106(4),456-460","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijpara.2020.04.010","volume":"50","author":"Sotillo J.","year":"2020","unstructured":"Sotillo J.; Robinson M.W.; Kimber M.J.; Cucher M.; Ancarola M.E.; Nejsum P.; Marcilla A.; Eichenberger R.M.; Tritten L.; The protein and microRNA cargo of extracellular vesicles from parasitic helminths - current status and research priorities. Int J Parasitol 2020,50(9),635-645","journal-title":"Int J Parasitol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/00005344-200212000-00005","volume":"40","author":"Wang L.","year":"2002","unstructured":"Wang L.; Karlsson L.; Moses S.; Hultg\u00e5rdh-Nilsson A.; Andersson M.; Borna C.; Gudbjartsson T.; Jern S.; Erlinge D.; P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 2002,40(6),841-853","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"C266","DOI":"10.1152\/ajpcell.00237.2010","volume":"300","author":"Lyubchenko T.","year":"2011","unstructured":"Lyubchenko T.; Woodward H.; Veo K.D.; Burns N.; Nijmeh H.; Liubchenko G.A.; Stenmark K.R.; Gerasimovskaya E.V.; P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Cell Physiol 2011,300(2),C266-C275","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"H285","DOI":"10.1152\/ajpheart.2000.279.1.H285","volume":"279","author":"Yamamoto K.","year":"2000","unstructured":"Yamamoto K.; Korenaga R.; Kamiya A.; Qi Z.; Sokabe M.; Ando J.; P2X(4) receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 2000,279(1),H285-H292","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"H1688","DOI":"10.1152\/ajpheart.00576.2003","volume":"286","author":"Liu C.","year":"2004","unstructured":"Liu C.; Mather S.; Huang Y.; Garland C.J.; Yao X.; Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries. Am J Physiol Heart Circ Physiol 2004,286(5),H1688-H1695","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1073\/pnas.1812947116","volume":"116","author":"Chen Q.","year":"2019","unstructured":"Chen Q.; Yang Y.; Hou J.; Shu Q.; Yin Y.; Fu W.; Han F.; Hou T.; Zeng C.; Nemeth E.; Linzmeier R.; Ganz T.; Fang X.; Increased gene copy number of DEFA1\/DEFA3 worsens sepsis by inducing endothelial pyroptosis. Proc Natl Acad Sci USA 2019,116(8),3161-3170","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=126","first-page":"822","volume":"139","year":"1998","unstructured":"M., Palmetshofer, A., Kaczmarek, E., Koziak, K., Stroka, D., Grey, S.T., Stuhlmeier, K.M., Robson, S.C. Extracellular ATP and ADP activate transcription factor NF-\u03baB and induce endothelial cell apoptosis. Biochem Biophys Res Commun 1998,139(7),822-829","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11302-013-9360-9","volume":"9","author":"Thimm D.","year":"2013","unstructured":"Thimm D.; Knospe M.; Abdelrahman A.; Moutinho M.; Alsdorf B.B.; von K\u00fcgelgen I.; Schiedel A.C.; M\u00fcller C.E.;  Characterization of new G protein-coupled adenine receptors in mouse and hamster Purinergic Signal 2013,9(3),415-426","journal-title":"Characterization of new G protein-coupled adenine receptors in mouse and hamster Purinergic Signal"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1051\/parasite\/1998054299","volume":"5","author":"Jacobs W.","year":"1998","unstructured":"Jacobs W.; Van de Vijver K.; Deelder A.; Van Marck E.; Morphometrical and immunopathological dissection of the hepatic Schistosoma haematobium granuloma in the murine host. Parasite 1998,5(4),299-306","journal-title":"Parasite"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1128\/IAI.64.11.4706-4713.1996","volume":"64","author":"Ritter D.M.","year":"1996","unstructured":"Ritter D.M.; McKerrow J.H.; Intercellular adhesion molecule 1 is the major adhesion molecule expressed during schistosome granuloma formation. Infect Immun 1996,64(11),4706-4713","journal-title":"Infect Immun"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1096-4959(01)00332-3","volume":"129","author":"Soliman K.","year":"2001","unstructured":"Soliman K.; El-Ansary A.; Mohamed A.M.; Effect of carnosine administration on metabolic parameters in bilharzia-infected hamsters. Comp Biochem Physiol B Biochem Mol Biol 2001,129(1),157-164","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11302-017-9571-6","volume":"13","author":"Zuccarini M.","year":"2017","unstructured":"Zuccarini M.; Giuliani P.; Buccella S.; Di Liberto V.; Mud\u00f2 G.; Belluardo N.; Carluccio M.; Rossini M.; Condorelli D.F.; Rathbone M.P.; Caciagli F.; Ciccarelli R.; Di Iorio P.; Modulation of the TGF-\u03b21-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells. Purinergic Signal 2017,13(4),429-442","journal-title":"Purinergic Signal"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/eji.201141869","volume":"41","author":"Barron L.","year":"2011","unstructured":"Barron L.; Wynn T.A.;  Macrophage activation governs schistosomiasis-induced inflammation and fibrosis Eur J Immunol 2011,41(9),2509-2514","journal-title":"Macrophage activation governs schistosomiasis-induced inflammation and fibrosis Eur J Immunol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1084\/jem.20091903","volume":"206","author":"Maizels R.M.","year":"2009","unstructured":"Maizels R.M.; Pearce E.J.; Artis D.; Yazdanbakhsh M.; Wynn T.A.; Regulation of pathogenesis and immunity in helminth infections. J Exp Med 2009,206(10),2059-2066","journal-title":"J Exp Med"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"13243","DOI":"10.1073\/pnas.231258498","volume":"98","author":"Rutitzky L.I.","year":"2001","unstructured":"Rutitzky L.I.; Hernandez H.J.; Stadecker M.J.; Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc Natl Acad Sci USA 2001,98(23),13243-13248","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","volume":"20","author":"Herbert D.R.","year":"2004","unstructured":"Herbert D.R.; H\u00f6lscher C.; Mohrs M.; Arendse B.; Schwegmann A.; Radwanska M.; Leeto M.; Kirsch R.; Hall P.; Mossmann H.; Claussen B.; F\u00f6rster I.; Brombacher F.; Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004,20(5),623-635","journal-title":"Immunity"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00018-010-0609-y","volume":"68","author":"Lopez-Castej\u00f3n G.","year":"2011","unstructured":"Lopez-Castej\u00f3n G.; Baroja-Mazo A.; Pelegr\u00edn P.; Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules. Cell Mol Life Sci 2011,68(18),3095-3107","journal-title":"Cell Mol Life Sci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"Geissmann F.","year":"2010","unstructured":"Geissmann F.; Manz M.G.; Jung S.; Sieweke M.H.; Merad M.; Ley K.; Development of monocytes, macrophages, and dendritic cells. Science 2010,327(5966),656-661","journal-title":"Science"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1440-1827.2007.02203.x","volume":"58","author":"Naito M.","year":"2008","unstructured":"Naito M.; Macrophage differentiation and function in health and disease. Pathol Int 2008,58(3),143-155","journal-title":"Pathol Int"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"Van den Bossche J.","year":"2017","unstructured":"Van den Bossche J.; O\u2019Neill L.A.; Menon D.;  Macrophage immunometabolism: where are we (Going)? Trends Immunol 2017,38(6),395-406","journal-title":"Macrophage immunometabolism: where are we (Going)? Trends Immunol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fphar.2018.00052","volume":"9","author":"Savio L.E.B.","year":"2018","unstructured":"Savio L.E.B.; de Andrade Mello P.; da Silva C.G.; Coutinho-Silva R.; The P2X7 Receptor in Inflammatory Diseases: Angel or Demon? Front Pharmacol 2018,9,52","journal-title":"Front Pharmacol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2017.00123","volume":"8","author":"Giuliani A.L.","year":"2017","unstructured":"Giuliani A.L.; Sarti A.C.; Falzoni S.; Di Virgilio F.; The P2X7 Receptor-Interleukin-1 Liaison. Front Pharmacol 2017,8,123","journal-title":"Front Pharmacol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-9255-4-5","volume":"4","author":"Lister M.F.","year":"2007","unstructured":"Lister M.F.; Sharkey J.; Sawatzky D.A.; Hodgkiss J.P.; Davidson D.J.; Rossi A.G.; Finlayson K.; The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) 2007,4,5","journal-title":"J Inflamm (Lond)"},{"key":"ref=143","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/134974","volume":"2014","author":"Oliveira S.D.","year":"2014","unstructured":"Oliveira S.D.; Nanini H.F.; Savio L.E.; Waghabi M.C.; Silva C.L.; Coutinho-Silva R.; Macrophage P2X7 receptor function is reduced during schistosomiasis: putative role of TGF- \u03b21. Mediators Inflamm 2014,2014","journal-title":"Mediators Inflamm"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.bbamem.2009.03.006","volume":"1788","author":"Welter-Stahl L.","year":"2009","unstructured":"Welter-Stahl L.; da Silva C.M.; Schachter J.; Persechini P.M.; Souza H.S.; Ojcius D.M.; Coutinho-Silva R.; Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells. Biochim Biophys Acta 2009,1788(5),1176-1187","journal-title":"Biochim Biophys Acta"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1590\/S0074-02761997000800005","volume":"92","author":"Lenzi H.L.","year":"1997","unstructured":"Lenzi H.L.; Pacheco R.G.; Pelajo-Machado M.; Panasco M.S.; Romanha W.S.; Lenzi J.A.; Immunological system and Schistosoma mansoni: co-evolutionary immunobiology. What is the eosinophil role in parasite-host relationship? Mem Inst Oswaldo Cruz 1997,92(Suppl. 2),19-32","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fimmu.2014.00496","volume":"5","author":"Spencer L.A.","year":"2014","unstructured":"Spencer L.A.; Bonjour K.; Melo R.C.; Weller P.F.; Eosinophil secretion of granule-derived cytokines. Front Immunol 2014,5,496","journal-title":"Front Immunol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ijpara.2005.02.017","volume":"35","author":"Davies S.J.","year":"2005","unstructured":"Davies S.J.; Smith S.J.; Lim K.C.; Zhang H.; Purchio A.F.; McKerrow J.H.; West D.B.; In vivo imaging of tissue eosinophilia and eosinopoietic responses to schistosome worms and eggs. Int J Parasitol 2005,35(8),851-859","journal-title":"Int J Parasitol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"18478","DOI":"10.1073\/pnas.0804547105","volume":"105","author":"Neves J.S.","year":"2008","unstructured":"Neves J.S.; Perez S.A.; Spencer L.A.; Melo R.C.; Reynolds L.; Ghiran I.; Mahmudi-Azer S.; Odemuyiwa S.O.; Dvorak A.M.; Moqbel R.; Weller P.F.; Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc Natl Acad Sci USA 2008,105(47),18478-18483","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","volume":"67","author":"Savio L.E.B.","year":"2017","unstructured":"Savio L.E.B.; de Andrade Mello P.; Figliuolo V.R.; de Avelar Almeida T.F.; Santana P.T.; Oliveira S.D.S.; Silva C.L.M.; Feldbr\u00fcgge L.; Csizmadia E.; Minshall R.D.; Longhi M.S.; Wu Y.; Robson S.C.; Coutinho-Silva R.; CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol 2017,67(4),716-726","journal-title":"J Hepatol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","volume":"9","author":"Jacob F.","year":"2013","unstructured":"Jacob F.; P\u00e9rez Novo C.; Bachert C.; Van Crombruggen K.; Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 2013,9(3),285-306","journal-title":"Purinergic Signal"},{"key":"ref=151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139805","volume":"10","author":"Muniz V.S.","year":"2015","unstructured":"Muniz V.S.; Baptista-Dos-Reis R.; Benjamim C.F.; Mata-Santos H.A.; Pyrrho A.S.; Strauch M.A.; Melo P.A.; Vicentino A.R.; Silva-Paiva J.; Bandeira-Melo C.; Weller P.F.; Figueiredo R.T.; Neves J.S.;  Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response PLoS One 2015,10(10)","journal-title":"Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response PLoS One"},{"key":"ref=152","volume":"2019","author":"Abbracchio MP","year":"2019","unstructured":"Abbracchio MP; Boeynaems JM; Boyer JL; Burnstock G; Ceruti S; Fumagalli M; Gachet C; Hills R; Humphries RG; Inoue K; Jacobson KA; Kennedy C; King BF; Lecca D; Miras-Portugal MT; M\u00fcller CE; Ralevic V; Weisman GA;  P2Y receptors (version 20194) in the IUPHAR\/BPS Guide to Pharmacology Database IUPHAR\/BPS Guide to Pharmacology 2019,2019(4)","journal-title":"P2Y receptors (version 20194) in the IUPHAR\/BPS Guide to Pharmacology Database IUPHAR\/BPS Guide to Pharmacology"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.2174\/138161212803582504","volume":"18","author":"Schuchardt M.","year":"2012","unstructured":"Schuchardt M.; T\u00f6lle M.; van der Giet M.; P2Y purinoceptors as potential emerging therapeutical target in vascular disease. Curr Pharm Des 2012,18(37),6169-6180","journal-title":"Curr Pharm Des"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/186249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/186249\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/186249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T14:55:38Z","timestamp":1641135338000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/186249\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":153,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026620666200924115113","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}